206 related articles for article (PubMed ID: 24078451)
1. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case-control studies.
Liang H; Yan Y; Li T; Li R; Li M; Li S; Qin X
Tumour Biol; 2014 Feb; 35(2):1695-701. PubMed ID: 24078451
[TBL] [Abstract][Full Text] [Related]
2. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
3. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
Yi K; Yang L; Lan Z; Xi M
Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
[TBL] [Abstract][Full Text] [Related]
4. The relevance of MTHFR C677T, A1298C, and MTRR A66G polymorphisms with response to male infertility in Asians: A meta-analysis.
Shi TL; Wu Y; Li Y; Chen ZF; Ma YN; Zhang ZT; Zhang YH; Zhang L
Medicine (Baltimore); 2019 Feb; 98(8):e14283. PubMed ID: 30813130
[TBL] [Abstract][Full Text] [Related]
5. MTHFR C677T, A1298C and MS A2756G Gene Polymorphisms and Male Infertility Risk in a Chinese Population: A Meta-Analysis.
Ren Z; Ren P; Yang B; Fang K; Ren S; Liao J; Liu S; Liu L; Peng Z; Dong Q
PLoS One; 2017; 12(1):e0169789. PubMed ID: 28081209
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase A1298C polymorphism and diabetes risk: evidence from a meta-analysis.
Yan Y; Liang H; Yang S; Wang J; Xie L; Qin X; Li S
Ren Fail; 2014 Aug; 36(7):1013-7. PubMed ID: 24828322
[TBL] [Abstract][Full Text] [Related]
7. ASSOCIATION OF MTHFR A1298C POLYMORPHISM WITH BREAST CANCER AND/OR OVARIAN CANCER RISK: AN UPDATED META-ANALYSIS.
Liu W; Li Y; Li R; Han X; Ma Y; Liu B; Kong X
Afr J Tradit Complement Altern Med; 2016; 13(5):72-86. PubMed ID: 28487897
[TBL] [Abstract][Full Text] [Related]
8. The association between 5, 10 - methylenetetrahydrofolate reductase and the risk of unexplained recurrent pregnancy loss in China: A Meta-analysis.
Wang G; Lin Z; Wang X; Sun Q; Xun Z; Xing B; Li Z
Medicine (Baltimore); 2021 Apr; 100(17):e25487. PubMed ID: 33907097
[TBL] [Abstract][Full Text] [Related]
9. Association of methylenetetrahydrofolate reductase (
Yang R; Pu D; Tan R; Wu J
Arch Endocrinol Metab; 2022 Sept 08; 66(4):551-581. PubMed ID: 35758831
[TBL] [Abstract][Full Text] [Related]
10. Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.
Wu YL; Ding XX; Sun YH; Yang HY; Sun L
J Neurol Sci; 2013 Dec; 335(1-2):14-21. PubMed ID: 24064257
[TBL] [Abstract][Full Text] [Related]
11. Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.
Xiong Y; Bian C; Lin X; Wang X; Xu K; Zhao X
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32639550
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in breast cancer.
Zhong S; Chen Z; Yu X; Li W; Tang J; Zhao J
Mol Biol Rep; 2014 Sep; 41(9):5775-85. PubMed ID: 24973876
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis.
Bai R; Liu W; Zhao A; Zhao Z; Jiang D
Mol Biol Rep; 2013 Mar; 40(3):2419-30. PubMed ID: 23229495
[TBL] [Abstract][Full Text] [Related]
14. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility.
Xia LZ; Liu Y; Xu XZ; Jiang PC; Ma G; Bu XF; Zhang YJ; Yu F; Xu KS; Li H
World J Gastroenterol; 2014 Aug; 20(32):11429-38. PubMed ID: 25170232
[TBL] [Abstract][Full Text] [Related]
15. The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.
Lv L; Wang P; Sun B; Chen G
Tumour Biol; 2014 Jan; 35(1):227-37. PubMed ID: 23897558
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between methylenetetrahydrofolate reductase gene A1298C polymorphism and breast cancer susceptibility.
Qiu LX; Zhang J; Li WH; Zhang QL; Yu H; Wang BY; Wang LP; Wang JL; Wang HJ; Liu XJ; Luo ZG; Wu XH
Mol Biol Rep; 2011 Apr; 38(4):2295-9. PubMed ID: 21052845
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of MTHFR C677T with preterm birth and low birth weight susceptibility: a meta-analysis.
Wu H; Zhu P; Geng X; Liu Z; Cui L; Gao Z; Jiang B; Yang L
Arch Gynecol Obstet; 2017 May; 295(5):1105-1118. PubMed ID: 28283826
[TBL] [Abstract][Full Text] [Related]
18. Association between MTHFR C677T polymorphism and thyroid cancer risk: a meta-analysis.
Yan Y; Han F; Fu H; Xia W; Qin X
Tumour Biol; 2014 Aug; 35(8):7707-12. PubMed ID: 24805831
[TBL] [Abstract][Full Text] [Related]
19. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
20. Associations between C677T and A1298C polymorphisms of MTHFR and susceptibility to rheumatoid arthritis: a systematic review and meta-analysis.
Yuan Y; Shao W; Li Y
Rheumatol Int; 2017 Apr; 37(4):557-569. PubMed ID: 28175955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
